CINECA IRIS Institutional Research Information System

MATTIELLO, Luigi
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.222
AS - Asia 2.404
EU - Europa 2.022
SA - Sud America 397
Continente sconosciuto - Info sul continente non disponibili 249
AF - Africa 54
OC - Oceania 8
Totale 9.356
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.069
SG - Singapore 983
CN - Cina 679
IT - Italia 446
VN - Vietnam 343
BR - Brasile 297
DE - Germania 254
IE - Irlanda 252
FR - Francia 227
FI - Finlandia 224
UA - Ucraina 214
KR - Corea 145
SE - Svezia 131
GB - Regno Unito 99
CA - Canada 83
PL - Polonia 60
HK - Hong Kong 53
BD - Bangladesh 44
AT - Austria 39
IN - India 35
JP - Giappone 33
AR - Argentina 28
EC - Ecuador 22
SN - Senegal 20
CO - Colombia 19
IQ - Iraq 18
MX - Messico 17
NL - Olanda 17
ID - Indonesia 16
JM - Giamaica 14
GR - Grecia 11
VE - Venezuela 11
ZA - Sudafrica 11
BE - Belgio 10
PK - Pakistan 9
CR - Costa Rica 8
MA - Marocco 8
NP - Nepal 8
RU - Federazione Russa 8
BB - Barbados 7
CL - Cile 7
ES - Italia 5
HN - Honduras 5
EG - Egitto 4
JO - Giordania 4
LT - Lituania 4
PY - Paraguay 4
RO - Romania 4
SV - El Salvador 4
UY - Uruguay 4
AE - Emirati Arabi Uniti 3
AU - Australia 3
CH - Svizzera 3
FJ - Figi 3
IR - Iran 3
KE - Kenya 3
MY - Malesia 3
PE - Perù 3
SI - Slovenia 3
TT - Trinidad e Tobago 3
UZ - Uzbekistan 3
AZ - Azerbaigian 2
BG - Bulgaria 2
BO - Bolivia 2
BZ - Belize 2
GI - Gibilterra 2
MU - Mauritius 2
NG - Nigeria 2
NI - Nicaragua 2
NZ - Nuova Zelanda 2
PH - Filippine 2
PR - Porto Rico 2
SY - Repubblica araba siriana 2
TR - Turchia 2
AL - Albania 1
AM - Armenia 1
BA - Bosnia-Erzegovina 1
BM - Bermuda 1
CW - ???statistics.table.value.countryCode.CW??? 1
CY - Cipro 1
DK - Danimarca 1
DZ - Algeria 1
ET - Etiopia 1
GE - Georgia 1
GP - Guadalupe 1
GT - Guatemala 1
HR - Croazia 1
HU - Ungheria 1
IL - Israele 1
KG - Kirghizistan 1
KW - Kuwait 1
KY - Cayman, isole 1
KZ - Kazakistan 1
LB - Libano 1
LC - Santa Lucia 1
LV - Lettonia 1
OM - Oman 1
PA - Panama 1
PS - Palestinian Territory 1
PT - Portogallo 1
Totale 9.102
Salva come PNG Salva come JPEG
Città #
Singapore 510
Beijing 493
San Jose 462
Santa Clara 451
Ashburn 255
Dublin 251
Chandler 222
Jacksonville 141
Los Angeles 120
Buffalo 109
Ho Chi Minh City 107
Medford 105
Villeurbanne 99
Milan 98
Princeton 95
Ann Arbor 88
Wilmington 87
Council Bluffs 77
The Dalles 75
Houston 74
Hanoi 73
Lauterbourg 73
Dallas 71
Torino 70
Dearborn 69
Nyköping 67
Columbus 64
Rome 58
Warsaw 57
Fairfield 51
Fremont 51
Munich 47
Hong Kong 45
New York 42
Boston 37
Vienna 33
Tokyo 29
Helsinki 24
Lachine 20
Toronto 20
Turku 20
São Paulo 19
Woodbridge 19
Da Nang 18
Verona 18
Dong Ket 17
Frankfurt am Main 17
Phoenix 17
Atlanta 16
Guangzhou 16
Norwalk 16
Orem 16
Brooklyn 15
Chicago 14
Philadelphia 14
Seoul 14
Seattle 13
Athens 11
Cambridge 11
Chennai 11
Hefei 11
Naples 11
Turin 11
Biên Hòa 10
Falls Church 10
Haiphong 10
Kunming 10
Memphis 10
Nuremberg 10
Amsterdam 9
Brussels 9
Falkenstein 9
London 9
Pisa 9
Denver 8
Montreal 8
Nanjing 8
Porto Alegre 8
Quito 8
San Francisco 8
Baghdad 7
Belo Horizonte 7
Boardman 7
Bologna 7
Curitiba 7
Kingston 7
Nanchang 7
Pasadena 7
Rio de Janeiro 7
Shenyang 7
Bridgetown 6
Campinas 6
Detroit 6
Guayaquil 6
Las Vegas 6
Mumbai 6
Shanghai 6
Charlotte 5
Dakar 5
Dhaka 5
Totale 5.545
Salva come PNG Salva come JPEG
Nome #
NPY-Y1 coexpressed with NPY-Y5 receptors modulate anxiety but not mild social stress response in mice 270
A short-term incubation with high glucose impairs VASP phosphorylation at serine 239 in response to the nitric oxide/cGMP pathway in vascular smooth muscle cells: role of oxidative stress. 203
High glucose reduces the anti-aggregating effect of aspirin by impairing the aspirin-induced activation of the nitric oxide/cGMP/PKG pathway. 195
Effects of high glucose on vascular endothelial growth factor synthesis and secretion in aortic vascular smooth muscle cells from obese and lean zucker rats. 178
Aspirin resistant subjects present a proinflammatory milieu with an increased oxidative stress: in these conditions, high glucose fails to influence platelet responses to agonists. 161
Effects of diltiazem on thromboxane B2 production from platelet-rich plasma and whole blood 157
C-reactive protein increases matrix metalloproteinase-2 expression and activity in cultured human vascular smooth muscle cells 148
Insulin activates vascular endothelial growth factor in vascular smooth muscle cells: influence of nitric oxide and of insulin resistance 148
Comparison between the effects of the rapid recombinant insulin analog aspart and those of human regular insulin on platelet cyclic nucleotides and aggregation. 146
An intensive control of blood glucose improves platelet sensitivity to aspirin in type 2 diabetes mellitus. 146
Adenosine increases human platelet levels of cGMP through nitric oxide: possible role in its antiaggregating effect. 145
Insulin influences the nitric oxide cyclic nucleotide pathway in cultured human smooth muscle cells from corpus cavernosum by rapidly activating a constitutive nitric oxide synthase. 144
Il miglioramento del controllo glicemico riduce la resistenza piastrinica all'aspirina nei pazienti affetti da diabete di tipo 2 144
High glucose reduces the anti-aggreganting effect of aspirin by impairing the aspirin-induced activation of the nitric oxide/cGMP/PKG pathway. 143
Arginine vasopressin release from human platelets after irreversible aggregation. 142
A short-term improvement of blood glucose control increases aspirin sensitivity in aspirin-resistant type 2 diabetic men. 142
Impairment of GLP-1 effects in platelets from subjects affected by type 2 diabetes mellitus 140
Role of NMDA receptor in homocysteine-induced activation of Mitogen-Activated Protein Kinase and Phosphatidyl Inositol 3-Kinase pathways in cultured human vascular smooth muscle cells 139
Nitric oxide activates PI3-K and MAPK signalling pathways in human and rat vascular smooth muscle cells: influence of insulin resistance and oxidative stress. 139
Effect of dopamine on adenosine 3',5'-cyclic monophosphate levels in human platelets. 138
GLP-1 reduces the activation of PI3K and MAPK pathways and of oxidative stress induced by Na-arachidonate in platelets. 137
Resistance to the GLP-1 effects on platelets in type 2 diabetes mellitus 137
In Central Obesity, Weight Loss Restores Platelet Sensitivity to Nitric Oxide and Prostacyclin 137
High Glucose Inhibits the Aspirin-Induced Activation of the Nitric Oxide/cGMP/cGMP-Dependent Protein Kinase Pathway and Does Not Affect the Aspirin-Induced Inhibition of Thromboxane Synthesis in Human Platelets. 136
Acido oleico e regolazione del VEGF in cellule muscolari lisce vascolari aortiche in condizioni di insulino-sensibilità e insulino-resistenza. 135
Desensitization of the platelet aggregation response to adrenaline during insulin-induced hypoglycaemia in man. 134
Calcium-channel blocking agents verapamil and diltiazem are inhibitors of vasopressin-induced human platelet activation. 134
Glucagon-Like Peptide 1 reduces platelet activation: effects on PI-3K and MAPK pathways and oxidative stress in the presence of arachidonic acid. 134
High glucose rapidly activates the nitric oxide/cyclic nucleotide pathway in human platelets via an osmotic mechanism 129
Effects of forskolin and organic nitrate on aggregation and intracellular cyclic nucleotide content in human platelets. 129
GLP-1 influences the inhibitory effects of nitric oxide on platelets. 123
Sodium azide, a bacteriostatic preservative contained in commercially available laboratory reagents, influences the responses of human platelets via the cGMP/PKG/VASP pathway. 120
Catecholamines, via beta-adrenoceptors, increase intracellular concentrations of 3',5'-cyclic guanosine monophosphate (cGMP) through nitric oxide in human platelets. 120
Oleic acid increases synthesis and secretion of VEGF in rat vascular smooth muscle cells: role of oxidative stress and impairment in obesity. 118
Glucagon-Like Peptide 1 reduces platelet activation induced by sodium arachidonate through the inhibition of PI-3K and MAPK pathways. 118
A comparison of the predictive power for overall blood glucose control of a 'good' fasting level in type 2 diabetic patients on diet alone or with oral agents 117
Resistance to the GLP-1 effects on platelets in type 2 diabetes mellitus. 116
GLP-1 and liraglutide increase the platelet inhibitory effects of nitric oxide. 113
A Platelet Defect Characterised by Absent Adrenaline-induced Aggregation and Lack of Secondary Aggregation in Response to ADP and Platelet-activating Factor. 109
Influence of oleic acid on vascular endothelial growth factor synthesis and secretion in aortic vascular smooth muscle cells: signalling molecules involved and role of insulin resistance 109
Insulin activates hypoxia-inducible factor-1alpha in human and rat vascular smooth muscle cells via phosphatidylinositol-3 kinase and mitogen-activated protein kinase pathways: impairment in insulin resistance owing to defects in insulin signalling 108
L'acido oleico incrementa trascrizione, sintesi e secrezione del VEGF in cellule muscolari lisce vascolari aortiche: ridotto effetto in condizioni di insulino-resistenza 105
Il GLP-1 aumenta l'effetto inibitorio dell'ossido nitrico sulle piastrine con meccanismo GLP-1R indipendente. 105
Resistance to the nitric oxide/cyclic guanosine 5'-monophosphate/protein kinase G pathway in vascular smooth muscle cells from the obese Zucker rat, a classical animal model of insulin resistance: role of oxidative stress 105
Nonenzymatic glycation of fibronectin impairs adhesive and proliferative properties of human vascular smooth muscle cells. 104
Homocysteine rapidly increases matrix metalloproteinase-2 expression and activity in cultured human vascular smooth muscle cells. Role of phosphatidyl inositol 3-kinase and mitogen activated protein kinase pathways 101
Insulin, at physiological concentrations, enhances the polymorphonuclear leukocyte chemotactic properties. 99
Studies on in vitro effect of picotamide on human platelet aggregation in platelet-rich plasma and whole blood. 99
Human vascular smooth muscle cells express a constitutive nitric oxide synthase that insulin rapidly activates, thus increasing guanosine 3':5'-cyclic monophosphate and adenosine 3':5'-cyclic monophosphate concentrations. 98
Platelet resistance to nitrates in obesity and obese NIDDM, and normal platelet sensitivity to both insulin and nitrates in lean NIDDM. 97
Studies on the effect of dopamine on the human platelet response. 94
Occurrence of low blood glucose concentrations during the afternoon in type 2 (non-insulin-dependent) diabetic patients on oral hypoglycaemic agents: importance of blood glucose monitoring. 93
Insulin stimulates the polymorphonuclear leukocyte chemokinesis. 92
Insulin stimulates nitric oxide synthesis in human platelets and, through nitric oxide, increases platelet concentrations of both guanosine-3', 5'-cyclic monophosphate and adenosine-3', 5'-cyclic monophosphate 91
Influenza dell’alto glucosio sull’aggregazione piastrinica in soggetti aspirino-trattati. 91
Interplay between milrinone and adenosine in the inhibition of human platelet response. 91
Insulin increases guanosine-3',5'-cyclic monophosphate in human platelets. A mechanism involved in the insulin anti-aggregating effect. 90
N-acetyl-L-cysteine exerts direct anti-aggregating effect on human platelets. 90
Intrahepatic exIntrahepatic expression of c-fos, c-myb and c-myc oncogenes: correlation with virus-induced chronic liver disease and response to interferon. 90
Studies on inhibition of human platelet function by sodium nitroprusside. Kinetic evaluation of the effect on aggregation and cyclic nucleotide content. 89
The activity of constitutive nitric oxide synthase is increased by the pathway cAMP/cAMP-activated protein kinase in human platelets. New insights into the antiaggregating effects of cAMP-elevating agents 87
Phenothiazines inhibit collagen-induced thromboxane B2 synthesis and increase forskolin anti-aggregating effects in human platelets. 86
Non-HDL cholesterol is a determinant of aspirin-resistance in type 2 diabetes mellitus. 86
Glyceryl trinitrate enhances the adenosine-induced inhibition of platelet responses: a mechanism potentially involved in the in vivo anti-aggregating effects of organic nitrates. 86
Pancreatic elastase-1 in stools, a marker of exocrine pancreas function, correlates with both residual beta-cell secretion and metabolic control in type 1 diabetic subjects 84
Insulin exerts opposite effects on platelet function at physiological and supraphysiological concentrations. 84
L-arginine modulates aggregation and intracellular cyclic 3',5'-guanosine monophosphate levels in human platelets: direct effect and interplay with antioxidative agent. 84
Platelet resistance to the antiaggregating effect of N-acetyl-L-cysteine in obese, insulin-resistant subjects. 84
Studies on inhibition of human platelet response by diltiazem. 83
The insulin-induced increase of guanosine-3',5'-cyclic monophosphate in human platelets is mediated by nitric oxide. 83
Insulin influences the renin-angiotensin-aldosterone system in humans. 82
Influence of protamine on adhesion, chemotaxis and proliferation of human vascular smooth muscle cells. 81
Impaired synthesis and action of antiaggregating cyclic nucleotides in platelets from obese subjects: possible role in platelet hyperactivation in obesity 81
Phenothiazine compounds enhance phentolamine effects on platelet aggregation and thromboxane B2 production. 79
Insulin increases cyclic nucleotide content in human vascular smooth muscle cells: a mechanism potentially involved in insulin-induced modulation of vascular tone. 78
Insulin-induced hypoglycaemia increases plasma concentrations of angiotensin II and does not modify atrial natriuretic polypeptide secretion in man. 76
Insulin influences immunoreactive endothelin release by human vascular smooth muscle cells. 75
Impaired insulin-induced platelet anti-aggregating effect in obesity and in obese non-insulin-dependent diabetes mellitus 73
Studies on the influence of insulin on cyclic adenosine monophosphate in human vascular smooth muscle cells: dependence on cyclic guanosine monophosphate and modulation of catecholamine effects. 72
Modulation of human platelet function by L-canavanine. Differentail effects of low and high concentrations 72
Moderate exercise increases platelet function in type I diabetic patients without severe angiopathy and in good control. 71
Organic nitrates and compounds that increase intraplatelet cyclic guanosine monophosphate (cGMP) levels enhance the antiaggregating effects of the stable prostacyclin analogue iloprost 64
Totale 9.356
Salva come PNG Salva come JPEG
Categoria #
all - tutte 30.083
article - articoli 0
book - libri 0
conference - conferenze 8.071
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 38.154
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022449 0 0 8 10 8 6 13 19 11 37 154 183
2022/2023760 105 52 22 30 72 249 86 41 66 15 19 3
2023/2024280 29 61 10 18 18 47 1 2 0 7 24 63
2024/20251.613 2 173 43 71 534 78 16 60 152 62 80 342
2025/20263.096 315 88 294 223 323 101 497 66 194 346 149 500
2026/2027597 174 361 62 0 0 0 0 0 0 0 0 0
Totale 9.356